In the BioHarmony Drug Report Database

"Preview" Icon

Pamidronate

Aredia, Pamidronate Disodium (pamidronic acid) is a small molecule pharmaceutical. Pamidronic acid was first approved as Aredia on 1991-10-31. It is used to treat extramammary paget disease, hypercalcemia, osteolysis, and postmenopausal osteoporosis in the USA. The pharmaceutical is active against farnesyl pyrophosphate synthase.

 

Trade Name

 

Aredia, Pamidronate Disodium
 

Common Name

 

pamidronic acid
 

ChEMBL ID

 

CHEMBL834
 

Indication

 

extramammary paget disease, hypercalcemia, osteolysis, postmenopausal osteoporosis
 

Drug Class

 

Calcium metabolism regulators

Image (chem structure or protein)

Pamidronate structure rendering